期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

CD44_(V6)与肿瘤 被引量：1

暂未订购
导出
作者 孙瑜
机构地区 浙江海洋学院医学院内科
出处 《中国实验诊断学》 2006年第1期108-109,F0003,共3页 Chinese Journal of Laboratory Diagnosis
基金 浙江省教育厅科研计划项目(20050121) 浙江省舟山市科技局科技计划项目(05579)
关键词 肿瘤标志 CD44V6 细胞黏附分子 致病因素 分子生物学 人类健康 一级预防 早期诊断 高危人群 免疫学
分类号 R730.4 [医药卫生—肿瘤] R735.2 [医药卫生—肿瘤]
  • 相关文献

参考文献22

  • 1Polverine PJ.Cellular adhesion molecules:newly idenlified mediators of angiogenesis[J].AMJ Pathol,1996,148:1023.
  • 2Fukuse T,Hirata T,Naiki H,et al.Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases[J].Cancer,1999,86(7):1174.
  • 3Wielenga VJ.Heider K H,Offerhaus GJ,et al.Experssion of CD44 variant proteins in human colorectal cancer is related to tumor progression[J].Caner Res,1993,53(20):4754.
  • 4Vinata BL,Lilly YW.Post-translational modification and expression of ankyrin-binding site in GP85(Pgp-1/CD44)and its biosynthetic precursors during T-lymphoma membrane biosynthetic precursors during T-lymphoma membrane biosynthesis[J].J Biol Chem,1991,266(27):17983.
  • 5徐钊.CD44分子与消化道肿瘤转移和预后评估的研究进展[J].国外医学（临床生物化学与检验学分册）,1998,19(3):111-113. 被引量：34
  • 6Mulder JW,Kruyt PM,Sewnath M,et al.Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins[J].Lancet,1994,344(8935):1470.
  • 7Ropponen K M,Eskelinen MJ,Lipponen PK,et al.Expression of CD44 and variant proteins in human colorectal and its relevatice for prognosis[J].Scand J Gastroenterol,1998,33(3):301.
  • 8姜希宏,张军,马榕.粘附分子与乳腺癌的侵袭和转移[J].国外医学（肿瘤学分册）,1998,25(2):103-105. 被引量：21
  • 9Fasano M,Sabatini MT,Wieczorek R,et al.CD44 and its V6 spliced variant in lung trmors:a role in histogenesis?[J].Cancer,1997,80(1):34.
  • 10Iida N,BOurguignon LY,New CD44 splice variants associated with human breast cancers[J].J Cell Physiol,1995,162(1):127.

二级参考文献14

  • 1刘鹏飞,吴孟超,陈汉,钱光相,傅继梁.原发性肝癌CD44v　mRNA表达与肝癌复发的关系[J].第二军医大学学报,1996,17(6):561-563. 被引量：5
  • 2[1]Kleiner DE, Stetler-Stevenson WG. Quantitative zymography:detection of picogram quantities of gelatinases[J]. Anal Biochem, 1994, 218(2): 325 - 329.
  • 3[2]Young TN, Rodriguz GC, Rinehart AR, et al. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2[J].Gynecologic Oncology, 1996, 62 ( 1 ): 89 - 99.
  • 4[3]Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease [ J ]. Cancer, 1999, 85 ( 1 ): 178 - 187.
  • 5[4]Mori A, Arii S, Furutani M, et al. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes[J]. Gene Therapy, 2000, 7(12): 1027-1033.
  • 6[5]Zebrowski BK, Liu W, Ramirez K, et al. Markedly elevated levels of vascular endothelial growth factor in malignant ascites[J]. Ann Sury Oncol, 1999,6(4), 6:373 - 378.
  • 7[6]Hasumi Y, Mizukami H, Urabe M, et al. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer[J]. Cancer Research, 2002, 62(2):2019-2023.
  • 8[7]Peterson RM, Yu Q, Stamenkovic I, et al. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites[J]. American Journal of Pathology, 2000; 156(6): 2159 - 2167.
  • 9[8]Fishman DA, Bafetti LM, Banionis S, et al. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells[J]. Cancer, 1997, 80(3): 1457 - 1463.
  • 10[9]Macaulay VM, O'Byrne KJ, Saunders MP, et al. Phase 1 study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions[J].Clinical Cancer Research, 1999, 5 (3): 513 - 520.

共引文献77

同被引文献15

  • 1李艳萍,史福军,曹兴明,汪艳丽.凋亡调节蛋白FasL,Fas和P53在乳腺癌的表达及其意义[J].解剖科学进展,2007,13(2):115-118. 被引量：4
  • 2Noguchi M, Katev N, Miyazaki I. Diagnosis of axillary lymph node metastases in patients with breast cancer. Breast Cancer Res Treat,1996,40:283-293.
  • 3Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer, 1996, 78: 10-16.
  • 4Wajant H, Pfizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev, 2003, 14: 53-66.
  • 5Budd RC. Death receptors couple to both cell proliferation and apoptosis. J Clin Invest, 2002, 109: 437-441.
  • 6Lens SM, Kataoka T, Fortner KA, et al. The caspase 8 inhibitor c-FLIP (L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol, 2002, 22: 5419-5433.
  • 7Kataoka T, ho M, Budd RC, et al. Expression level of c-FLIP versus Fas determines susceptibility to Fas ligand-induced cell death in murine thymoma EL-4 cells. Exp Cell Res, 2002, 273: 256-264.
  • 8Desbarats J, Newell MK. Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med, 2000, 6: 920-923.
  • 9Reiehmann E. The biological role of the Fas/FasL system during tumor formation and progression. Semin Cancer Biol, 2002, 12: 309-315.
  • 10Houston A, O'Connell J. The Fas signalling pathway and its role in the pathogenesis of cancer. Curr Opin Pharmacol, 2004, 4: 321-326.

引证文献1

二级引证文献3

中国实验诊断学
2006年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部